Cargando…
Neutral lipid storage disease with myopathy: A 10-year follow-up case report
Mutations in PNPLA2 gene encoding for adipose triglyceride lipase (ATGL), involved in triglyceride degradation, lead to an inborn error of neutral lipid metabolism. The disorder that results in abnormal storage of neutral lipid is known as neutral lipid storage disease with myopathy (NLSDM). We repo...
Autores principales: | Missaglia, Sara, Tavian, Daniela, Angelini, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295162/ https://www.ncbi.nlm.nih.gov/pubmed/35713537 http://dx.doi.org/10.4081/ejtm.2022.10645 |
Ejemplares similares
-
MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy
por: Pegoraro, Valentina, et al.
Publicado: (2019) -
Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function
por: Missaglia, Sara, et al.
Publicado: (2019) -
Metabolic lipid muscle disorders: biomarkers and
treatment
por: Angelini, Corrado, et al.
Publicado: (2019) -
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients
por: Noguera, Nelida Inés, et al.
Publicado: (2023) -
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement
por: Missaglia, Sara, et al.
Publicado: (2017)